Indication
Periprosthetic Joint Infection
13 clinical trials
24 products
Clinical trial
An Open-Label Multicenter Study to Evaluate the Safety and Efficacy of PhageBank™ Phage Therapy in Conjunction With Debridement, Antibiotics, and Implant Retention (DAIR) for Patients With First Time Culture Proven Chronic Prosthetic Joint InfectionStatus: Withdrawn, Estimated PCD: 2023-11-01
Product
Phage TherapyClinical trial
A Randomized Controlled Trial of Alternating Irrigation of Vancomycin Hydrochloride and Tobramycin Sulfate in Patients Undergoing Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection (PJI) of the Hip or KneeStatus: Completed, Estimated PCD: 2023-03-13
Product
Standard of CareProduct
VT-X7Product
TRL1068Clinical trial
A Phase 1, Blinded, Single Ascending Dose Study to Evaluate Safety, Pharmacokinetics, and Activity of TRL1068 in Subjects With Prosthetic Joint Infection of the Knee or Hip, Undergoing Primary Two Stage Exchange ArthroplastyStatus: Completed, Estimated PCD: 2024-03-13
Product
TNP-2092Clinical trial
An Open-Label Study to Evaluate Tissue Distribution, Plasma Pharmacokinetics, Safety, and Tolerability After a Single Intravenous Dose of TNP-2092 in Adult Participants Undergoing Primary Total Hip or Knee ArthroplastyStatus: Completed, Estimated PCD: 2021-12-31
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of APT Phage Bank Phage Therapy Versus Placebo in Conjunction With Debridement, Antibiotics, and Implant Retention (DAIR) in Subjects With Chronic Prosthetic Joint Infection (PJI)Status: Withdrawn, Estimated PCD: 2025-07-01
Product
PlaceboProduct
BacteriophageClinical trial
Prospective Randomized Evaluation of Emerging Novel Treatments for Infection Prophylaxis in Total Joint Replacement (PREVENT-iT)Status: Recruiting, Estimated PCD: 2028-11-01
Product
Chlorhexidine GluconateProduct
VancomycinClinical trial
Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. The ABOGRAFT TrialStatus: Recruiting, Estimated PCD: 2029-12-01
Product
Vancomycin + TobramycinProduct
SalineClinical trial
Prospective Randomized Evaluation of Emerging Novel Treatments for Infection Prophylaxis in Total Joint Replacement: A Pilot StudyStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Product
ChlorhexidineProduct
Topical AntibioticProduct
Saline LavageClinical trial
Dalbavancin For The Treatment Of Gram Positive Osteomyelitis Or Joint Infections Including Prosthetic Hip Or Knee InfectionsStatus: Completed, Estimated PCD: 2022-12-31
Product
DalbavancinClinical trial
Effects of Photodynamic Therapy on the Human Inguinal Skin Microbiome to Improve Antiseptic Effect - Pilot 3Status: Recruiting, Estimated PCD: 2023-09-01
Product
Photodynamic TherapyClinical trial
Randomized Clinical Trial Determining Proper Duration of Suppressive Antibiotic Therapy After Total Joint Arthroplasty Debridement, Antibiotics, and Implant RetentionStatus: Recruiting, Estimated PCD: 2026-01-01
Product
6 months of SATProduct
SATProduct
Indefinite SATClinical trial
Preoperative Daptomycin Prophylaxis for Preventing Gram-Positive or Methicillin-Resistant Staphylococcus Aureus Infection in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded TrialStatus: Not yet recruiting, Estimated PCD: 2026-07-31
Product
Cefazolin + DaptomycinProduct
Cefazolin + VancomycinClinical trial
Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a ProtocolStatus: Completed, Estimated PCD: 2022-05-25
Product
Intraosseous vancomycin